MoneyWorks4Me

Granules India board to consider un-audited financial results

22 Oct 2018 Evaluate

Granules India has informed that meeting of the Board of Directors of the Company is scheduled to be held on Monday, the 29th day of October 2018 at 4.00 PM at the registered office of the Company to consider the un-audited financial results for the second quarter of the FY 2018-19 and to consider the payment of second interim dividend for the FY 2018-19 if any, was submitted vide application number 392027.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1759.50
Dr. Reddys Labs. 1199.95
Cipla 1305.55
Lupin 1953.50
Zydus Lifesciences 1117.60
View more..